Perrigo Company plc Foreign Currency Exchange Rate, Remeasurement
Perrigo Company plc (PRGO) had Foreign Currency Exchange Rate, Remeasurement of 0.28 USD/ILS as of 2018-09-29, per its 10-Q filed 2018-11-08.
Discontinued › Notes
us-gaap:ForeignCurrencyExchangeRateRemeasurement1 · last filed 2018-11-08
- 2018-03-31: Foreign Currency Exchange Rate, Remeasurement 0.28%.
- 2017-12-31: Foreign Currency Exchange Rate, Remeasurement 0.28%.
- 2017-09-30: Foreign Currency Exchange Rate, Remeasurement 0.28%.
- 2017-07-01: Foreign Currency Exchange Rate, Remeasurement 0.28%.
pure
| Period end | Foreign Currency Exchange Rate, Remeasurement |
|---|---|
| 2018-03-31 | 0.28% 10-Q · filed 2018-05-08 |
| 2017-12-31 | 0.28% 10-K · filed 2018-03-01 |
| 2017-09-30 | 0.28% 10-Q · filed 2017-11-09 |
| 2017-07-01 | 0.28% 10-Q · filed 2017-08-10 |
USD/ILS
| Period end | Foreign Currency Exchange Rate, Remeasurement |
|---|---|
| 2018-09-29 | 0.28 USD/ILS 10-Q · filed 2018-11-08 |
| 2018-06-30 | 0.28 USD/ILS 10-Q · filed 2018-08-09 |
| 2018-03-31 | 0.00 USD/ILS 10-Q · filed 2018-05-08 |
| 2017-12-31 | 0.00 USD/ILS 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |